Portola Pharma (PTLA) Receives $100 Million Milestone Payment from HealthCare Royalty Partners for FDA Approval of Andexxa
Tweet Send to a Friend
Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the company has received a $100 million milestone payment from HealthCare Royalty ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
